PharmiWeb

YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene ...

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced ...
PharmiWeb

Electric Metals (USA) Limited Announces Agreement to Sell Non-Core Nevada Silver Assets

WILMINGTON, DE / ACCESS Newswire / March 13, 2026 / Electric Metals (USA) Limited (TSXV:EML)(OTCQB:EMUSF) (the "Company") a U.S.-based critical minerals and advanced materials company, today announced ...